High Nuclear Expression of HDGF Correlates with Disease Progression and Poor Prognosis in Human Endometrial Carcinoma

Table 1

Correlation between the clinicopathologic characteristics and nuclear expression of HDGF protein in EC.

HDGF (%)
Characteristics	𝑁	High expression	Low expression	𝑃
Age
<50	42	10 (23.8%)	32 (76.2%)	0.830
≧50	80	21 (26.3%)	59 (73.7%)
Menopausal status
Premenopausal	65	15 (23.1%)	50 (76.9%)	0.537
Postmenopausal	57	16 (28.1%)	41 (71.9%)
FIGO stage
I-II	90	18 (20%)	72 (80%)	0.032
III	32	13 (40.6%)	19 (59.4%)
Histological grading
G1	44	15 (34.1%)	29 (65.9%)	0.140
G2	62	11 (17.7%)	51 (82.3%)
G3	16	5 (31.3%)	11 (68.7%)
Depth of myometrial invasion
<50%	85	19 (22.4%)	66 (77.6%)	0.263
≧50%	37	12 (32.4%)	25 (67.6%)
Lymph node status
Negative	105	25 (23.8%)	80 (76.2%)	0.369
Positive	17	6 (35.3%)	11 (64.7%)